Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study

Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study

Background Effective treatment options are limited for elderly patients with acute myeloid leukemia (AML). A prospective phase II study was conducted to investigate the safety and efficacy of pegylated liposomal doxorubicin (PLD) combined with low-dose cytarabine (LDAC) and granulocyte colony-stimul...

Full description

Saved in:
Bibliographic Details
Main Authors: Bingqing Luo PhD, Xiaoyan Tan MD, Yanfang Zhang MS, Xiao Hu MS, Hanqing Zeng MD, Hongbo Xiao MS, Shifeng Lou BS, Kang Zhou BS
Format: Article
Language:English
Published: SAGE Publishing 2025-03-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338241312436
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/15330338241312436

Similar Items